Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)

The summary for the Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional): The purpose of this notice of funding opportunity (NOFO) is to support applications from small businesses to develop solutions for commercialization that enable regional genomic medicine eConsult Service.

Federal Grant Title:	Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-24-107
Type of Funding:	Grant
CFDA Numbers:	93.172
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 30th, 2024
Original Application Deadline:	May 30th, 2024
Posted Date:	January 9th, 2024
Creation Date:	January 9th, 2024
Archive Date:	July 5th, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 9th, 2024

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-24-107.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed); • Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed); • NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed); • Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult ...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed); • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required); • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...; • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...; • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...